INTIStock
Inhibitor Therapeutics, Inc.
Price data unavailable
Track INTI in your trading journalAbout Inhibitor Therapeutics, Inc.
Inhibitor Therapeutics, Inc. (INTI) is a publicly listed company on US equity markets.
INHIBITOR THERAPTICS INC
The company reports trailing twelve-month revenue of $0 and net loss of $686,425.
Key metrics include a return on equity of 34.7%, a debt-to-equity ratio of -1.72.
Use FINOTAUR to track INTI's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $0 |
| Net Income (TTM) | $-686,425 |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 34.70% |
| Debt-to-Equity | -1.72 |
| Dividend per Share | — |
Want real-time analysis on INTI?
Track it free in your trading journal. Log trades, tag setups, and review your edge.